Carysil Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 2, 2025, 8:32 pm

Market Cap	1,806 Cr.
Current Price	637
High / Low	1,035/482
Stock P/E	29.8
Book Value	174
Dividend Yield	0.31 %
ROCE	17.1 %
ROE	17.6 %
Face Value	2.00
PEG Ratio	3.51

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Carysil Ltd

Competitors of Carysil Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Exxaro Tiles Ltd	274 Cr.	6.12	12.0/5.30		6.09	0.00 %	4.54 %	0.72 %	1.00
Carysil Ltd	1,806 Cr.	637	1,035/482	29.8	174	0.31 %	17.1 %	17.6 %	2.00
Somany Ceramics Ltd	1,755 Cr.	429	873/402	25.6	180	0.70 %	14.4 %	12.9 %	2.00
Orient Bell Ltd	374 Cr.	260	447/215	74.7	213	0.19 %	0.97 %	0.34 %	10.0
Nitco Ltd	845 Cr.	118	149/58.0		82.2	0.00 %	14.0 %	%	10.0
Industry Average	2,955.11 Cr	812.60		85.83	191.13	0.52%	11.54%	19.41%	6.10

All Competitor Stocks of Carysil Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	128	139	171	139	138	146	142	164	188	191	201	207	203
Expenses	100	111	138	117	113	119	116	131	153	156	165	170	174
Operating Profit	28	28	34	22	25	26	26	33	35	35	36	37	29
OPM %	22%	20%	20%	16%	18%	18%	18%	20%	19%	18%	18%	18%	14%
Other Income	2	2	0	0	0	1	1	1	1	2	1	2	4
Interest	2	3	3	4	4	4	5	5	6	6	6	6	6
Depreciation	5	5	6	6	7	7	7	8	8	9	9	10	9
Profit before tax	23	22	25	13	14	16	16	22	22	21	23	24	18
Tax %	25%	25%	25%	26%	15%	23%	25%	28%	31%	26%	30%	27%	31%
Net Profit	17	17	19	9	12	12	12	16	15	16	16	17	13
EPS in Rs	6.47	6.13	6.98	3.46	4.50	4.64	4.32	5.76	5.72	5.79	5.91	5.91	4.40

Last Updated: February 28, 2025, 12:42 pm

Below is a detailed analysis of the quarterly data for Carysil Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹203.00 Cr.. The value appears to be declining and may need further review. It has decreased from 207.00 Cr. (Sep 2024) to ₹203.00 Cr., marking a decrease of 4.00 Cr..
For Expenses, as of Dec 2024, the value is ₹174.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 170.00 Cr. (Sep 2024) to ₹174.00 Cr., marking an increase of 4.00 Cr..
For Operating Profit, as of Dec 2024, the value is ₹29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Sep 2024) to ₹29.00 Cr., marking a decrease of 8.00 Cr..
For OPM %, as of Dec 2024, the value is 14.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Sep 2024) to 14.00%, marking a decrease of 4.00%.
For Other Income, as of Dec 2024, the value is ₹4.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Sep 2024) to ₹4.00 Cr., marking an increase of 2.00 Cr..
For Interest, as of Dec 2024, the value is ₹6.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 6.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Sep 2024) to ₹9.00 Cr., marking a decrease of 1.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Sep 2024) to ₹18.00 Cr., marking a decrease of 6.00 Cr..
For Tax %, as of Dec 2024, the value is 31.00%. The value appears to be increasing, which may not be favorable. It has increased from 27.00% (Sep 2024) to 31.00%, marking an increase of 4.00%.
For Net Profit, as of Dec 2024, the value is ₹13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Sep 2024) to ₹13.00 Cr., marking a decrease of 4.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 4.40. The value appears to be declining and may need further review. It has decreased from 5.91 (Sep 2024) to 4.40, marking a decrease of 1.51.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 1:40 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	80	106	127	174	181	196	252	276	310	484	594	684	802
Expenses	66	87	103	143	154	169	209	229	243	379	484	553	666
Operating Profit	14	19	24	31	27	27	42	48	67	105	110	131	136
OPM %	17%	18%	19%	18%	15%	14%	17%	17%	22%	22%	18%	19%	17%
Other Income	1	1	1	2	3	5	2	5	8	10	2	5	10
Interest	4	5	8	9	11	8	12	10	8	11	17	23	23
Depreciation	4	5	4	5	6	7	9	12	13	18	26	32	37
Profit before tax	6	10	13	18	13	17	24	30	54	86	68	81	86
Tax %	22%	25%	32%	32%	37%	28%	28%	25%	27%	24%	22%	28%
Net Profit	5	8	9	12	8	12	17	23	39	65	53	58	61
EPS in Rs	2.17	3.43	3.75	4.21	2.80	4.61	6.65	8.27	14.65	24.26	19.58	21.59	22.01
Dividend Payout %	30%	23%	21%	24%	36%	22%	18%	15%	14%	10%	10%	9%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	60.00%	12.50%	33.33%	-33.33%	50.00%	41.67%	35.29%	69.57%	66.67%	-18.46%	9.43%
Change in YoY Net Profit Growth (%)	0.00%	-47.50%	20.83%	-66.67%	83.33%	-8.33%	-6.37%	34.27%	-2.90%	-85.13%	27.90%

Carysil Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	20%
5 Years:	22%
3 Years:	30%
TTM:	26%

Compounded Profit Growth
10 Years:	22%
5 Years:	27%
3 Years:	14%
TTM:	11%

Stock Price CAGR
10 Years:	19%
5 Years:	60%
3 Years:	-11%
1 Year:	-40%

Return on Equity
10 Years:	18%
5 Years:	20%
3 Years:	21%
Last Year:	18%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 2:01 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	4	5	5	5	5	5	5	5	5	5	5	5	6
Reserves	23	29	37	74	107	113	130	152	186	248	298	349	489
Borrowings	31	39	73	67	80	92	97	102	107	150	235	312	260
Other Liabilities	20	23	32	52	41	50	59	65	93	150	174	178	218
Total Liabilities	79	97	147	199	233	260	291	325	391	553	712	845	973
Fixed Assets	32	35	58	67	98	111	119	125	152	206	328	404	402
CWIP	0	2	4	2	2	2	4	9	10	21	14	10	13
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	46	60	85	131	132	146	168	191	229	326	371	431	558
Total Assets	79	97	147	199	233	260	291	325	391	553	712	845	973

Below is a detailed analysis of the balance sheet data for Carysil Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹6.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2024) to ₹6.00 Cr., marking an increase of 1.00 Cr..
For Reserves, as of Sep 2024, the value is ₹489.00 Cr.. The value appears strong and on an upward trend. It has increased from 349.00 Cr. (Mar 2024) to ₹489.00 Cr., marking an increase of 140.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹260.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 312.00 Cr. (Mar 2024) to ₹260.00 Cr., marking a decrease of 52.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹218.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 178.00 Cr. (Mar 2024) to ₹218.00 Cr., marking an increase of 40.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹973.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 845.00 Cr. (Mar 2024) to ₹973.00 Cr., marking an increase of 128.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹402.00 Cr.. The value appears to be declining and may need further review. It has decreased from 404.00 Cr. (Mar 2024) to ₹402.00 Cr., marking a decrease of 2.00 Cr..
For CWIP, as of Sep 2024, the value is ₹13.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to ₹13.00 Cr., marking an increase of 3.00 Cr..
For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹558.00 Cr.. The value appears strong and on an upward trend. It has increased from 431.00 Cr. (Mar 2024) to ₹558.00 Cr., marking an increase of 127.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹973.00 Cr.. The value appears strong and on an upward trend. It has increased from 845.00 Cr. (Mar 2024) to ₹973.00 Cr., marking an increase of 128.00 Cr..

Notably, the Reserves (₹489.00 Cr.) exceed the Borrowings (260.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	2	6	7	11	6	16	24	30	45	52	71	58
Cash from Investing Activity +	-7	-9	-27	-13	-14	-20	-17	-19	-35	-73	-136	-102
Cash from Financing Activity +	6	4	25	19	2	-0	-4	-10	-9	18	64	48
Net Cash Flow	1	0	5	17	-6	-5	2	1	2	-2	-1	5

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-17.00	-20.00	-49.00	-36.00	-53.00	-65.00	-55.00	-54.00	-40.00	-45.00	-125.00	-181.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	97	86	93	89	77	89	79	82	98	76	63	74
Inventory Days	199	206	239	184	216	213	170	180	161	212	184	248
Days Payable	146	131	120	174	138	167	99	87	124	162	111	124
Cash Conversion Cycle	150	160	212	99	155	135	150	175	136	126	137	197
Working Capital Days	97	94	116	98	123	127	121	125	136	117	109	125
ROCE %	19%	23%	22%	20%	14%	12%	16%	16%	22%	27%	18%	17%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	44.04%	43.91%	43.91%	43.91%	43.91%	43.84%	43.84%	43.84%	43.84%	43.80%	41.37%	41.37%
FIIs	0.36%	0.26%	0.26%	0.27%	0.28%	0.34%	0.56%	0.64%	0.87%	0.70%	1.22%	1.29%
DIIs	6.24%	6.22%	6.37%	6.45%	6.41%	6.71%	7.08%	7.31%	7.32%	7.20%	11.09%	11.69%
Government	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.76%	0.00%	0.00%	0.00%	0.00%
Public	49.36%	49.60%	49.45%	49.37%	49.40%	49.11%	48.52%	46.46%	47.96%	48.31%	46.32%	45.66%
No. of Shareholders	49,115	53,747	61,978	65,688	65,311	61,770	59,964	58,189	57,986	58,019	59,032	59,880

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
LIC MF Multi Cap Fund	100,001	1.06	9.82	29,746	2025-04-02	236.18%
LIC MF Small Cap Fund	29,746	1.4	2.92	29,746	2025-04-02	0%
Motilal Oswal Nifty Microcap 250 Index Fund	20,522	0.23	1.96	29,746	2025-04-02	-31.01%
Quantum Small Cap Fund	9,136	2.25	0.87	29,746	2025-04-02	-69.29%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	2.00	2.00	2.00	2.00	2.00
Basic EPS (Rs.)	21.59	19.59	24.26	14.66	8.38
Diluted EPS (Rs.)	21.55	19.52	24.13	14.66	8.38
Cash EPS (Rs.)	33.86	29.58	31.08	19.47	13.03
Book Value[Excl.RevalReserv]/Share (Rs.)	133.55	114.69	96.25	72.66	60.00
Book Value[Incl.RevalReserv]/Share (Rs.)	133.55	114.69	96.25	72.66	60.00
Revenue From Operations / Share (Rs.)	254.98	221.83	181.27	116.02	103.48
PBDIT / Share (Rs.)	50.00	40.71	42.48	27.65	19.15
PBIT / Share (Rs.)	37.90	30.86	35.84	22.90	14.69
PBT / Share (Rs.)	30.12	25.44	32.25	20.17	11.42
Net Profit / Share (Rs.)	21.76	19.73	24.45	14.73	8.56
NP After MI And SOA / Share (Rs.)	21.59	19.58	24.26	14.66	8.27
PBDIT Margin (%)	19.60	18.34	23.43	23.82	18.50
PBIT Margin (%)	14.86	13.91	19.76	19.73	14.19
PBT Margin (%)	11.81	11.46	17.78	17.38	11.03
Net Profit Margin (%)	8.53	8.89	13.48	12.69	8.27
NP After MI And SOA Margin (%)	8.46	8.82	13.38	12.63	7.99
Return on Networth / Equity (%)	16.35	17.27	25.52	20.43	13.98
Return on Capital Employeed (%)	20.74	20.55	30.78	27.17	21.25
Return On Assets (%)	6.85	7.35	11.70	10.00	6.80
Long Term Debt / Equity (X)	0.32	0.25	0.15	0.11	0.13
Total Debt / Equity (X)	0.84	0.72	0.54	0.49	0.56
Asset Turnover Ratio (%)	0.87	0.93	0.91	0.76	0.79
Current Ratio (X)	1.17	1.16	1.27	1.33	1.33
Quick Ratio (X)	0.67	0.74	0.83	1.00	0.89
Inventory Turnover Ratio (X)	1.80	1.98	2.47	1.80	1.76
Dividend Payout Ratio (NP) (%)	9.26	6.12	9.89	13.64	14.10
Dividend Payout Ratio (CP) (%)	5.93	4.07	7.76	10.30	9.15
Earning Retention Ratio (%)	90.74	93.88	90.11	86.36	85.90
Cash Earning Retention Ratio (%)	94.07	95.93	92.24	89.70	90.85
Interest Coverage Ratio (X)	6.43	7.50	11.83	10.11	5.86
Interest Coverage Ratio (Post Tax) (X)	3.80	4.64	7.81	6.38	3.62
Enterprise Value (Cr.)	2921.68	1669.06	2347.37	903.84	221.77
EV / Net Operating Revenue (X)	4.27	2.81	4.85	2.92	0.80
EV / EBITDA (X)	21.79	15.32	20.70	12.25	4.34
MarketCap / Net Operating Revenue (X)	3.85	2.45	4.58	2.67	0.54
Retention Ratios (%)	90.73	93.87	90.10	86.35	85.89
Price / BV (X)	7.43	4.80	8.74	4.32	0.94
Price / Net Operating Revenue (X)	3.85	2.45	4.58	2.67	0.54
EarningsYield	0.02	0.03	0.02	0.04	0.14

After reviewing the key financial ratios for Carysil Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
For Basic EPS (Rs.), as of Mar 24, the value is 21.59. This value is within the healthy range. It has increased from 19.59 (Mar 23) to 21.59, marking an increase of 2.00.
For Diluted EPS (Rs.), as of Mar 24, the value is 21.55. This value is within the healthy range. It has increased from 19.52 (Mar 23) to 21.55, marking an increase of 2.03.
For Cash EPS (Rs.), as of Mar 24, the value is 33.86. This value is within the healthy range. It has increased from 29.58 (Mar 23) to 33.86, marking an increase of 4.28.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 133.55. It has increased from 114.69 (Mar 23) to 133.55, marking an increase of 18.86.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 133.55. It has increased from 114.69 (Mar 23) to 133.55, marking an increase of 18.86.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 254.98. It has increased from 221.83 (Mar 23) to 254.98, marking an increase of 33.15.
For PBDIT / Share (Rs.), as of Mar 24, the value is 50.00. This value is within the healthy range. It has increased from 40.71 (Mar 23) to 50.00, marking an increase of 9.29.
For PBIT / Share (Rs.), as of Mar 24, the value is 37.90. This value is within the healthy range. It has increased from 30.86 (Mar 23) to 37.90, marking an increase of 7.04.
For PBT / Share (Rs.), as of Mar 24, the value is 30.12. This value is within the healthy range. It has increased from 25.44 (Mar 23) to 30.12, marking an increase of 4.68.
For Net Profit / Share (Rs.), as of Mar 24, the value is 21.76. This value is within the healthy range. It has increased from 19.73 (Mar 23) to 21.76, marking an increase of 2.03.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 21.59. This value is within the healthy range. It has increased from 19.58 (Mar 23) to 21.59, marking an increase of 2.01.
For PBDIT Margin (%), as of Mar 24, the value is 19.60. This value is within the healthy range. It has increased from 18.34 (Mar 23) to 19.60, marking an increase of 1.26.
For PBIT Margin (%), as of Mar 24, the value is 14.86. This value is within the healthy range. It has increased from 13.91 (Mar 23) to 14.86, marking an increase of 0.95.
For PBT Margin (%), as of Mar 24, the value is 11.81. This value is within the healthy range. It has increased from 11.46 (Mar 23) to 11.81, marking an increase of 0.35.
For Net Profit Margin (%), as of Mar 24, the value is 8.53. This value is within the healthy range. It has decreased from 8.89 (Mar 23) to 8.53, marking a decrease of 0.36.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 8.46. This value is within the healthy range. It has decreased from 8.82 (Mar 23) to 8.46, marking a decrease of 0.36.
For Return on Networth / Equity (%), as of Mar 24, the value is 16.35. This value is within the healthy range. It has decreased from 17.27 (Mar 23) to 16.35, marking a decrease of 0.92.
For Return on Capital Employeed (%), as of Mar 24, the value is 20.74. This value is within the healthy range. It has increased from 20.55 (Mar 23) to 20.74, marking an increase of 0.19.
For Return On Assets (%), as of Mar 24, the value is 6.85. This value is within the healthy range. It has decreased from 7.35 (Mar 23) to 6.85, marking a decrease of 0.50.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.32. This value is within the healthy range. It has increased from 0.25 (Mar 23) to 0.32, marking an increase of 0.07.
For Total Debt / Equity (X), as of Mar 24, the value is 0.84. This value is within the healthy range. It has increased from 0.72 (Mar 23) to 0.84, marking an increase of 0.12.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.87. It has decreased from 0.93 (Mar 23) to 0.87, marking a decrease of 0.06.
For Current Ratio (X), as of Mar 24, the value is 1.17. This value is below the healthy minimum of 1.5. It has increased from 1.16 (Mar 23) to 1.17, marking an increase of 0.01.
For Quick Ratio (X), as of Mar 24, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.74 (Mar 23) to 0.67, marking a decrease of 0.07.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.80. This value is below the healthy minimum of 4. It has decreased from 1.98 (Mar 23) to 1.80, marking a decrease of 0.18.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 9.26. This value is below the healthy minimum of 20. It has increased from 6.12 (Mar 23) to 9.26, marking an increase of 3.14.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 5.93. This value is below the healthy minimum of 20. It has increased from 4.07 (Mar 23) to 5.93, marking an increase of 1.86.
For Earning Retention Ratio (%), as of Mar 24, the value is 90.74. This value exceeds the healthy maximum of 70. It has decreased from 93.88 (Mar 23) to 90.74, marking a decrease of 3.14.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 94.07. This value exceeds the healthy maximum of 70. It has decreased from 95.93 (Mar 23) to 94.07, marking a decrease of 1.86.
For Interest Coverage Ratio (X), as of Mar 24, the value is 6.43. This value is within the healthy range. It has decreased from 7.50 (Mar 23) to 6.43, marking a decrease of 1.07.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.80. This value is within the healthy range. It has decreased from 4.64 (Mar 23) to 3.80, marking a decrease of 0.84.
For Enterprise Value (Cr.), as of Mar 24, the value is 2,921.68. It has increased from 1,669.06 (Mar 23) to 2,921.68, marking an increase of 1,252.62.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.27. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 23) to 4.27, marking an increase of 1.46.
For EV / EBITDA (X), as of Mar 24, the value is 21.79. This value exceeds the healthy maximum of 15. It has increased from 15.32 (Mar 23) to 21.79, marking an increase of 6.47.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.85. This value exceeds the healthy maximum of 3. It has increased from 2.45 (Mar 23) to 3.85, marking an increase of 1.40.
For Retention Ratios (%), as of Mar 24, the value is 90.73. This value exceeds the healthy maximum of 70. It has decreased from 93.87 (Mar 23) to 90.73, marking a decrease of 3.14.
For Price / BV (X), as of Mar 24, the value is 7.43. This value exceeds the healthy maximum of 3. It has increased from 4.80 (Mar 23) to 7.43, marking an increase of 2.63.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.85. This value exceeds the healthy maximum of 3. It has increased from 2.45 (Mar 23) to 3.85, marking an increase of 1.40.
For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Carysil Ltd as of April 4, 2025 is: 732.34

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 4, 2025, Carysil Ltd is Undervalued by 14.97% compared to the current share price 637.00

Intrinsic Value of Carysil Ltd as of April 4, 2025 is: 794.45

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 4, 2025, Carysil Ltd is Undervalued by 24.72% compared to the current share price 637.00

Last 5 Year EPS CAGR: 8.48%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 18.83%, which is a positive sign. The company has higher reserves (171.92 cr) compared to borrowings (126.54 cr), indicating strong financial stability. The company has shown consistent growth in sales (328.15 cr) and profit (38.92 cr) over the years.	The stock has a high average Working Capital Days of 115.67, which may not be favorable. The stock has a high average Cash Conversion Cycle of 152.67, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Carysil Ltd:
1. Net Profit Margin: 8.53%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 20.74% (Industry Average ROCE: 11.54%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 16.35% (Industry Average ROE: 19.41%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 3.8
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.67
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 29.8 (Industry average Stock P/E: 85.83)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.84
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Carysil Ltd. is a Public Limited Listed company incorporated on 19/01/1987 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L26914MH1987PLC042283 and registration number is 042283. Currently Company is involved in the business activities of Manufacture of other plastics products. Company's Total Operating Revenue is Rs. 371.26 Cr. and Equity Capital is Rs. 5.36 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Ceramics/Tiles/Sanitaryware	A-702, 7th Floor, Kanakia Wall Street, Mumbai Maharashtra 400093	cs.al@acrysil.com https://www.carysil.com

Management
Name	Position Held
Mr. Chirag Parekh	Chairman & Managing Director
Mr. Anand Sharma	Executive Director & Group CFO
Dr. Sonal V Ambani	Independent Director
Mr. Rustam N Mulla	Independent Director
Mrs. Katja Larsen	Independent Director
Mr. Prabhakar R Dalal	Independent Director
Mr. Pradyumna R Vyas	Independent Director
Dr. Savan Godiawala	Independent Director

FAQ

What is the intrinsic value of Carysil Ltd?

Carysil Ltd's intrinsic value (as of 04 April 2025) is ₹732.34 — 14.97% higher the current market price of ₹637.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 1,806 Cr. market cap, FY2025-2026 high/low of ₹1,035/482, reserves of 489 Cr, and liabilities of 973 Cr.

What is the Market Cap of Carysil Ltd?

The Market Cap of Carysil Ltd is 1,806 Cr..

What is the current Stock Price of Carysil Ltd as on 04 April 2025?

The current stock price of Carysil Ltd as on 04 April 2025 is 637.

What is the High / Low of Carysil Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Carysil Ltd stocks is ₹1,035/482.

What is the Stock P/E of Carysil Ltd?

The Stock P/E of Carysil Ltd is 29.8.

What is the Book Value of Carysil Ltd?

The Book Value of Carysil Ltd is 174.

What is the Dividend Yield of Carysil Ltd?

The Dividend Yield of Carysil Ltd is 0.31 %.

What is the ROCE of Carysil Ltd?

The ROCE of Carysil Ltd is 17.1 %.

What is the ROE of Carysil Ltd?

The ROE of Carysil Ltd is 17.6 %.

What is the Face Value of Carysil Ltd?

The Face Value of Carysil Ltd is 2.00.